196 related articles for article (PubMed ID: 9815531)
1. Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
Bednarek AK; Sahin A; Brenner AJ; Johnston DA; Aldaz CM
Clin Cancer Res; 1997 Jan; 3(1):11-6. PubMed ID: 9815531
[TBL] [Abstract][Full Text] [Related]
2. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
He GP; Shui QL; Huang Y; Zhang SZ; Yu H
Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity in normal and neoplastic breast.
Tsao Jl; Zhao Y; Lukas J; Yang X; Shah A; Press M; Shibata D
Clin Cancer Res; 1997 Apr; 3(4):627-31. PubMed ID: 9815730
[TBL] [Abstract][Full Text] [Related]
4. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity in microdissected human breast cancer tissues: association with p53, p21 and outcome.
Mueller C; Riese U; Kosmehl H; Dahse R; Claussen U; Ernst G
Int J Oncol; 2002 Feb; 20(2):385-90. PubMed ID: 11788906
[TBL] [Abstract][Full Text] [Related]
6. [Telomerase activity in breast carcinoma].
Yang W; Xu L; Zhang T
Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):278-80. PubMed ID: 11776815
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity and its inhibition in benign and malignant breast lesions.
Sugino T; Yoshida K; Bolodeoku J; Tarin D; Goodison S
J Pathol; 1997 Sep; 183(1):57-61. PubMed ID: 9370948
[TBL] [Abstract][Full Text] [Related]
8. Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
Simícková M; Nekulová M; Pecen L; Cernoch M; Vagundová M; Pacovský Z
Neoplasma; 2001; 48(4):267-73. PubMed ID: 11712677
[TBL] [Abstract][Full Text] [Related]
9. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
[TBL] [Abstract][Full Text] [Related]
11. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis CM; Trangas T
Cancer Res; 2000 Oct; 60(19):5427-33. PubMed ID: 11034084
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.
Swellam M; Ismail M; Eissa S; Hamdy M; Mokhtar N
IUBMB Life; 2004 Aug; 56(8):483-90. PubMed ID: 15545228
[TBL] [Abstract][Full Text] [Related]
13. Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.
Yashima K; Milchgrub S; Gollahon LS; Maitra A; Saboorian MH; Shay JW; Gazdar AF
Clin Cancer Res; 1998 Jan; 4(1):229-34. PubMed ID: 9516976
[TBL] [Abstract][Full Text] [Related]
14. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.
Soria JC; Gauthier LR; Raymond E; Granotier C; Morat L; Armand JP; Boussin FD; Sabatier L
Clin Cancer Res; 1999 May; 5(5):971-5. PubMed ID: 10353728
[TBL] [Abstract][Full Text] [Related]
15. [Telomerase activity in infiltration ductal carcinoma of breast].
Wu S; Liu Z; Sun H
Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):515-6. PubMed ID: 10923461
[TBL] [Abstract][Full Text] [Related]
16. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
17. [Significance of telomerase expression in diagnosis and treatment of breast tumor].
Qiu XG; Liu YP; Pu QT; Gu QH; Han JJ
Ai Zheng; 2002 Nov; 21(11):1241-3. PubMed ID: 12526225
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples.
Hiyama E; Saeki T; Hiyama K; Takashima S; Shay JW; Matsuura Y; Yokoyama T
Cancer; 2000 Aug; 90(4):235-8. PubMed ID: 10966564
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in premalignant and malignant lesions of human oral mucosa.
Kannan S; Tahara H; Yokozaki H; Mathew B; Nalinakumari KR; Nair MK; Tahara E
Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):413-20. PubMed ID: 9184774
[TBL] [Abstract][Full Text] [Related]
20. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]